Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|2|206-215

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.2, 2012-03, pp. : 206-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy

By Doshi A.A.   Rogers J.   Kern M.J.   Hauptman P.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 90-92

Elsevier

Access to resources Recommend Favorite

Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-09 ,pp. : 706-719

Bentham Science Publishers

Access to resources Recommend Favorite

Use of rapamycin slows progression of cardiac transplantation vasculopathy

By Mancini D.   Pinney S.   Burkhoff D.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 44-44

Elsevier

Access to resources Recommend Favorite

Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions

By  

Current Vascular Pharmacology, Vol. 8, Iss. 2, 2010-03 ,pp. : 169-188

Bentham Science Publishers

Access to resources Recommend Favorite

Predictors of Allograft Ischemic Injury in Clinical Heart Transplantation

By Kjellman Ulf W.   Shariari Ali   Svensson Gunnar   Wiklund Lars   Bengtsson Anders   Ekroth Rolf  

Scandinavian Cardiovascular Journal, Vol. 36, Iss. 5, 2002-09 ,pp. : 313-318

Informa Healthcare

Access to resources Recommend Favorite